Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001214659-26-005747
Filing Date
2026-05-07
Accepted
2026-05-07 17:31:34
Documents
1
Period of Report
2026-05-05

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT marketforms-73069.html 4  
1 PRIMARY DOCUMENT marketforms-73069.xml 4 3702
  Complete submission text file 0001214659-26-005747.txt   5181
Mailing Address 30 TECHNOLOGY DRIVE WARREN NJ 07059
Business Address 30 TECHNOLOGY DRIVE WARREN NJ 07059 908-941-1900
Aquestive Therapeutics, Inc. (Issuer) CIK: 0001398733 (see all company filings)

EIN.: 208623253 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address 30 TECHNOLOGY DRIVE WARREN NJ 07059
Business Address
BRAENDER LORI J (Reporting) CIK: 0001752955 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-38599 | Film No.: 26955058